Aileen David-Wang
University of the Philippines Diliman
H-index: 11
Asia-Philippines
Top articles of Aileen David-Wang
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Intravenous Tocilizumab versus Standard of Care in the Treatment of Severe and Critical COVID-19-related Pneumonia: A Single Center, Double-blind, Placebo Controlled, Phase 3 Trial | Acta Medica Philippina | Eric Jason B Amante Aileen S David-Wang Michael L Tee Felix Eduardo R Punzalan John C Añonuevo | 2023/5/30 |
Utility of laboratory and immune biomarkers in predicting disease progression and mortality among patients with moderate to severe COVID-19 disease at a Philippine tertiary … | Frontiers in Immunology | Jaime Alfonso M Aherrera FER Punzalan JAM Aherrera SLM de Paz-Silava AV Mondragon | 2023/3/1 |
Validation of Filipino version of a questionnaire on work-related asthma among healthcare workers of the Philippine General Hospital: A prospective cross-sectional study | Philippine Journal of Internal Medicine | Joel M Santiaguel Mary-Grace P Quilloy-Arellano Adele H Espaldon Maria-Philina B Pablo Aileen S David-Wang | 2023 |
Purpose: This study was performed to determine the clinical biomarkers and cytokines that may be associated with disease progression and in-hospital mortality in a cohort of … | Pietro Ghezzi Andreu Comas-Garcia Andrew Weber Antonio Lalueza Jaime Alfonso M Aherrera | 2023 | |
OPEN ACCESS EDITED BY | Community Series-Extremophiles: Microbial Genomics and Taxogenomics, Volume II | José Luis Losada Asier Gonzalez-Artetxe Yousri Elghoul Júlio A Costa JA Costa | 2023/11/22 |
A randomized, double-blind, multicenter trial comparing efficacy and safety of imipenem/cilastatin/relebactam versus piperacillin/tazobactam in adults with hospital-acquired or … | Anesthesia & Analgesia | Tong J Gan Ashish C Sinha Anthony L Kovac R Kevin Jones Stephen A Cohen | 2009/5/1 |
Lessons Learned - Patient Communication During the Pandemic. | Malaysian Orthopedic Journal | EHM Wang I Real A David-Wang DA Rubio CL Gaston | 2021/3 |
Once-daily, single-inhaler mometasone–indacaterol–glycopyrronium versus mometasone–indacaterol or twice-daily fluticasone–salmeterol in patients with inadequately controlled … | The Lancet Resp Med | on behalf of the IRIDIUM trial investigators Kerstjens HAM Maspero J Chapman KR et al. | 2020/10/1 |
